Dexmedetomidine in IVRA

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 28, 2020

Primary Completion Date

March 25, 2021

Study Completion Date

June 20, 2021

Conditions
Regional Anesthesia Morbidity
Interventions
DRUG

Dexmedetomidine Injectable Solution [Dexdomitor]

two different doses of dexemedetomidine (0.25 μg /kg and 0.5 μg/kg) as adjunct to lignocaine in intravenous regional anesthesia for upper limb orthopedic surgeries

DRUG

Lidocaine IV

Intravenous regional anaesthesia

Trial Locations (1)

32511

Menoufia University, Shibīn al Kawm

All Listed Sponsors
lead

Menoufia University

OTHER

NCT05123170 - Dexmedetomidine in IVRA | Biotech Hunter | Biotech Hunter